Practical implication
Manufacturers must implement processes for device registration in swissdamed before placing devices on the market, with immediate attention needed for vigilance-reportable incidents.
From 1 July 2026, all medical devices and in vitro diagnostic medical devices must be registered in the swissdamed UDI Devices module. A transitional period allows for registration until 31 December 2026 for most devices, while immediate registration is required for incidents reportable to Swissmedic. The new rules replace class I notifications and introduce a fee structure for registrations. Fees include CHF 200 for the first device and CHF 20 for additional devices, with a maximum of CHF 10,000 charged annually per manufacturer.
What changed: The introduction of mandatory registration in swissdamed from 1 July 2026 replaces prior notification procedures for medical devices and IVDs.
Why it matters: This regulatory change enhances market surveillance and ensures that medical devices comply with safety standards before entering the market.
Practical implication: Manufacturers must implement processes for device registration in swissdamed before placing devices on the market, with immediate attention needed for vigilance-reportable incidents.
View original source
Published from the Firecrawl policy change extraction pipeline.